A systems biology approach to discovering pathway signaling dysregulation in metastasis

Robert Clarke1,2, Pavel Kraikivski3, Brandon C Jones4

  • 1Department of Oncology, Georgetown University Medical Center, 3970 Reservoir Rd NW, Washington, DC, 20057, USA. clarker@umn.edu.

Insights

Systems modeling offers a new approach to understanding cancer metastasis. This method addresses challenges like data complexity and tumor heterogeneity to identify novel therapeutic targets for metastatic disease.

Area of Science:

  • Oncology
  • Systems Biology
  • Computational Biology

Background:

  • Metastasis is the primary cause of cancer mortality, yet understanding of its complex mechanisms remains incomplete.
  • Few therapeutic agents specifically target the metastatic cascade, highlighting a critical need for novel strategies.
  • Current knowledge of gene and pathway interactions in metastasis is rudimentary, necessitating a more holistic view.

Purpose of the Study:

  • To introduce systems modeling as a framework for understanding cancer metastasis.
  • To define challenges in applying a multidisciplinary, systems-based approach to metastasis research.
  • To identify actionable therapeutic targets within the metastatic cascade.

Main Methods:

  • Conceptual introduction to systems modeling and its application to complex biological systems.
  • Discussion of challenges including high-dimensional omics data, knowledge gaps in metastasis, tumor heterogeneity, and sampling bias.
  • Overview of integrative modeling focusing on molecular signaling networks (nodes and edges).

Main Results:

  • Identified key challenges in applying systems modeling to metastasis, such as data complexity and tumor heterogeneity.
  • Highlighted the importance of a holistic, systems-based approach to unraveling metastasis.
  • Provided foundational concepts for developing a systems model of the metastatic cascade.

Conclusions:

  • Systems modeling presents a promising avenue for a comprehensive understanding of cancer metastasis.
  • Addressing identified challenges is crucial for advancing systems-based approaches in oncology.
  • Future research should focus on developing robust systems models to uncover novel therapeutic strategies for metastasis.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
51.2K